Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.36 | 0.30 | 20.56 |
| EPS, GAAP | 0.85 | 0.19 | 0.19 |
| Consensus Estimate | 0.44 | 0.47 | -6.38 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 1.84 | 1.65 | 10.95 |
| EPS, GAAP | 1.94 | 1.27 | 52.59 |
| Consensus Estimate | 2.26 | 2.29 | -1.23 |
| PFE | Industry Average | |
| P/E (TTM) | 21.96 | NA |
| P/E (Forward) | 12.79 | NA |
| PEG Ratio | 2.78 | 2.19 |
| Price/Sales | 3.68 | 18.50 |
| Beta | 0.76 | 0.70 |
| 8:47 AM | 4/4/2013 | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH |
| 6:39 AM | 4/4/2013 | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH |
| 4/5/2013 | 'Guided Missiles' to Treat Cancer (WSJ.com) |
| 4/3/2013 | Drug Firms Expand Powers to Recoup Pay (WSJ.com) |
| 4/3/2013 | Pfizer Recalls Thyroid Drug Over Odor (WSJ.com) |
| 4/2/2013 | Options Traders Position for Health-Care Pullback (WSJ.com) |
| 4/2/2013 | Citi Adds 11 U.S. Stocks To CDS-Screened Dividend Picks (Barrons.com) |
| 3/31/2013 | Vitamins Attract Consumer-Products Makers (WSJ.com) |
| 3/19/2013 | Corporate Cash Piles Up (24/7 Wall St) |
| 3/19/2013 | What’s Important in the Financial World (3/19/3013) (24/7 Wall St) |
